Literature DB >> 19859859

First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.

S Weigel1, W U Batzler, T Decker, H W Hense, W Heindel.   

Abstract

PURPOSE: To epidemiologically evaluate the impact of digital mammography screening on incidence rates and tumor characteristics for breast cancer.
MATERIALS AND METHODS: The first German digital screening units in the clinical routine were evaluated during the implementation period by using data from the cancer registry to compare the incidence rate of breast cancers and prognostic characteristics. 74 % of women aged 50 - 69 within the region of Muenster/Coesfeld/Warendorf were invited between 10 / 2005 and 12 / 2007 for initial screening; 55 % participated (n = 35 961).
RESULTS: In 2002 - 2004 the average breast cancer incidence rate (per 100,000) was 297.9. During the implementation of screening, the rate rose to 532.9 in 2007. Of the 349 cancers detected with screening, 76 % (265 / 349) were invasive compared to 90 % (546 / 608) of cases not detected with screening during the same period. 37 % (97 / 265) of cancers detected in the screening program had a diameter of <or= 10 mm and 75 % (198 / 265) were node-negative compared to 15 % (79 / 546) and 64 % (322 / 503), respectively, in cancers detected outside the screening program. The distribution of invasive tumor size (pT categories) and the nodal status differed with statistical significance between cancers detected in and outside the program (p = 0.005 and p = 0.004, respectively).
CONCLUSION: Epidemiological data shows that the implementation of a population-based screening program led to a relevant increase in the age-specific breast cancer incidence rate. The characteristics of breast cancers detected in the screening program comply with the requirements of the European guidelines and are significantly favorable compared to tumors diagnosed outside the program. These findings indicate that digital mammography screening fulfills the requirements for an early tumor detection tool.

Entities:  

Mesh:

Year:  2009        PMID: 19859859     DOI: 10.1055/s-0028-1109831

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  6 in total

1.  Mammography Screening: Evidence, History and Current Practice in Germany and Other European Countries.

Authors:  Cornelis Biesheuvel; Stefanie Weigel; Walter Heindel
Journal:  Breast Care (Basel)       Date:  2011-04-29       Impact factor: 2.860

2.  Differences in radiological patterns, tumour characteristics and diagnostic precision between digital mammography and screen-film mammography in four breast cancer screening programmes in Spain.

Authors:  Laia Domingo; Anabel Romero; Francesc Belvis; Mar Sánchez; Joana Ferrer; Dolores Salas; Josefa Ibáñez; Alfonso Vega; Francesc Ferrer; M Soledad Laso; Francesc Macià; Xavier Castells; Maria Sala
Journal:  Eur Radiol       Date:  2011-05-11       Impact factor: 5.315

3.  Differences in Breast Cancer Characteristics by Mammography Screening Participation or Non-Participation.

Authors:  Bettina Braun; Laura Khil; Joke Tio; Barbara Krause-Bergmann; Andrea Fuhs; Oliver Heidinger; Hans-Werner Hense
Journal:  Dtsch Arztebl Int       Date:  2018-08-06       Impact factor: 5.594

4.  The incidence of interval cancers in the German mammography screening program: results from the population-based cancer registry in North Rhine-Westphalia.

Authors:  Oliver Heidinger; Wolf Ulrich Batzler; Volker Krieg; Stefanie Weigel; Cornelis Biesheuvel; Walter Heindel; Hans-Werner Hense
Journal:  Dtsch Arztebl Int       Date:  2012-11-16       Impact factor: 5.594

5.  Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark.

Authors:  Annette Ø Jensen; Jacob B Jacobsen; Mette Nørgaard; Mellissa Yong; Jon P Fryzek; Henrik T Sørensen
Journal:  BMC Cancer       Date:  2011-01-24       Impact factor: 4.430

6.  Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer.

Authors:  Margit L H Riis; Torben Lüders; Anne-Jorunn Nesbakken; Hilde S Vollan; Vessela Kristensen; Ida R K Bukholm
Journal:  BMC Cancer       Date:  2010-12-16       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.